CORC  > 复旦大学上海医学院
An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004
Jin, Tao; Hu, Bingxue; Chen, Shanshan; Wang, Qiang; Dong, Xue; Zhang, Yin; Zhu, Yongqiang; Zhang, Zhao
刊名FRONTIERS IN PHARMACOLOGY
2018
卷号9
关键词FHND004 EGFR inhibitor human ether-a-go-go-related gene inhibitory effect cardiac safety
ISSN号1663-9812
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3603218
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Jin, Tao,Hu, Bingxue,Chen, Shanshan,et al. An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004[J]. FRONTIERS IN PHARMACOLOGY,2018,9.
APA Jin, Tao.,Hu, Bingxue.,Chen, Shanshan.,Wang, Qiang.,Dong, Xue.,...&Zhang, Zhao.(2018).An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004.FRONTIERS IN PHARMACOLOGY,9.
MLA Jin, Tao,et al."An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004".FRONTIERS IN PHARMACOLOGY 9(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace